THE US Food and Drug
Administration has announced the
launch of a new scheme which
aims to help health care providers
detect and report misleading
promotions for medications.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 12 May 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 May 10
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.